Summary:
A double blind, randomized 91 day treatment study of oral contraceptive vs placebo in evaluating the frequency and severity of menstrually related migraine headaches in otherwise healthy, reproductive aged women.
Qualified Participants Must:
• Be a female, 18-34 years of age
•
Have a history of migraine headaches without aura for at least 6 months
•
Have a history of migraine headaches associated with menstruation
•
No contraindications to oral contraceptive use
Qualified Participants May Receive:
Study related care, study medication. Reimbursement for time and travel may be available.